Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Longevity Group Co. Ltd. ( (HK:1863) ) has shared an announcement.
China Longevity Group Company Limited has scheduled a board meeting for 27 March 2026 to review and approve the audited final results of the company and its subsidiaries for the financial year ended 31 December 2025. The board will also consider the declaration of a final dividend, if any, signaling a forthcoming update on the group’s financial performance and potential shareholder returns.
The planned meeting indicates that the company is progressing on its reporting timetable and may provide clarity on earnings and capital allocation to investors. The announcement also reconfirms the current composition of the board, underscoring the presence of both executive and independent non-executive directors overseeing key financial and dividend decisions.
More about China Longevity Group Co. Ltd.
China Longevity Group Company Limited is a Cayman Islands-incorporated company listed in Hong Kong under stock code 1863. Its board comprises three executive directors, led by chairman and executive director Liu Jun, and three independent non-executive directors, reflecting a standard Hong Kong-listed corporate governance structure.
See more data about 1863 stock on TipRanks’ Stock Analysis page.